LRRK2 and Parkinson disease: This protocol was recently combined with a microfluidics system to generate a 3D cell culture model based on neurons derived from human neuro-epithelial stem cells (hNESCs) from PD patients carrying the LRRK2-G2019S mutation (Bolognin et al., 2019).